Call for Abstract

7th International Conference on Neuro-Oncology and Brain Tumor, will be organized around the theme “Neuro Oncology and Treating Brain Tumour challenges with COVID-19 pandemic”

NEURO ONCOLOGY 2021 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in NEURO ONCOLOGY 2021

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.


The Neuro oncology is denounced to various malevolent disorders of neurons. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, astrocytoma, brainstem glioma and pons, glioblastoma multiforme, and high-grade (highly anaplastic) astrocytoma. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures. The global central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2021, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.The neuro oncology which includes Ganglioglioneurocytoma, Germ cell tumor, Vascular brain tumors, Skull base tumors, Vestibular schwannomas, Germinoma, Glioblastoma multiforme (GBM), Glioblastoma, Glioma, Hemangioblastoma, Leptomeningeal disease (carcinomatous meningitis), Low-grade glioma, Lymphoma, Medulloblastoma, Meningioma, Neurofibromatosis, Oligodendroglioma, Pilocytic astrocytoma, Pineal gland parenchymal tumor, Pineal tumor, Pineoblastoma, Pituitary adenoma, Chordoma.

For more types of brain and spinal cord tumors are in below:

  • Track 1-1Acoustic neuromas
  • Track 1-2Lung cancer and metastatic brain tumors
  • Track 1-3Ganglioglioma
  • Track 1-4Brain Injury Rehabilitation
  • Track 1-5Surgical Neurooncology
  • Track 1-6Tumor Biomarkers
  • Track 1-7Ependymoma
  • Track 1-8Craniopharyngioma
  • Track 1-9Colloid cyst
  • Track 1-10Central nervous system (CNS) tumors
  • Track 1-11Brain stem glioma
  • Track 1-12Brain metastases
  • Track 1-13Astrocytoma
  • Track 1-14Astrocytic cancer
  • Track 1-15Anaplastic oligodendroglioma
  • Track 1-16Anaplastic oligoastrocytoma
  • Track 1-17Anaplastic mixed glioma
  • Track 1-18Anaplastic astrocytoma
  • Track 1-19Optic nerve glioma


A brain tumor is occurs when abnormal cells form within the brain. There are two main types of tumors: cancerous (malignant) tumors and benign (non-cancerous) tumors. Malignant tumors can be divided into primary tumors, which start within the brain, and secondary tumors,  

The symptoms of Brain stem tumors vary greatly and can include Ataxia, Cranial Nerve Palsy, headaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumor is inherently serious and life-threatening because of its invasive and infiltrative character in the limited space of the Intracranial Cavity.

Types of  Brain Tumors which includes:

  • Track 2-1Primary brain tumors
  • Track 2-2Secondary brain tumors
  • Track 2-3Grades of Brain Tumors
  • Track 2-4Benign brain tumors
  • Track 2-5Malignant brain tumors


Metastasis is defined as the process by which Cancer cells spread to other parts of the body. Metastatic Cancer is called as Stage IV cancer among many stages of it. Metastasis is one of the hallmarks of cancer distinguishing it from benign tumors. And it can spread to distant parts of the body.

  • Track 3-1Melanoma (skin cancer) and metastatic brain tumors
  • Track 3-2Kidney cancer and metastatic brain tumors
  • Track 3-3Metastases base of skull
  • Track 3-4Meningitis
  • Track 3-5Metastases neoplastic
  • Track 3-6Malignant melanoma
  • Track 3-7Causes and Symptoms of metastatic tumors
  • Track 3-8Intracranial Metastasis
  • Track 3-9Inter- intra tumour heterogeneity


Meningiomas usually grow inward slowly, causing pressure on the Brain or Spinal cord. They interfere with the normal functions of the Brain after reaching a large size. They represent about one-third of all Primary Brain Tumors and occur most frequently in middle-aged women.

  • Track 4-1Abnormal Chromosome 22
  • Track 4-2Platelet-Derived Growth Factor (PDGFR)
  • Track 4-3Epidermal Growth Factor Receptors (EGFR)
  • Track 4-4Spinal cord tumor in children
  • Track 4-5Skull base meningioma


Neoplasm is an abnormal growth of tissue, which forms a mass that commonly referred to as a Tumor. Neoplasm can be caused by an,that which can be caused by. Not all types of  cause a tumorous overgrowth of tissue. Malignant Neoplasms derived from epithelial cells are called Carcinomas.

  • Track 5-1Glioma
  • Track 5-2Glioblastoma Multiforme
  • Track 5-3Ependymoma
  • Track 5-4Pontine Glioma
  • Track 5-5Vestibular schwannoma
  • Track 5-6Unspecified glioma
  • Track 5-7Astrocytoma


Pediatric neurooncology encompasses a wide-variety of areas Pediatric neurosurgeons are quite completely different from those ordinarily seen by general neurosurgeons. Because Pediatric neurosurgical issues often are present for life, children with nervous system problems frequently require close, on-going follow-up from childhood - sometimes as early as the new-born period - through the teenage years.

The types of brain tumors most common in children are not the same as those most common in adults. Childhood brain tumors frequently appear in different locations and behave differently than brain tumors in adults.

These areas include: developmental, contextual, and psychosocial factors that can contribute to Pediatric psychological and physical issues. It additionally includes: the assessment, diagnosis and treatment of Pediatric medical conditions, prevention of Pediatric medical conditions (physical and psychological), educating the general population on Pediatric health, promoting health-related behaviours, advocating for child and family public policies, and improving Pediatric healthcare delivery services.

  • Track 6-1Adult and Pediatric brain tumors
  • Track 6-2Pediatric Psychological Disorders and Neuropsychiatric
  • Track 6-3Pediatric Neurogenetics and Neurodegenerative Disorders
  • Track 6-4Pediatric Neuro-immunology Disorders
  • Track 6-5Clinical trials and case studies in Pediatric
  • Track 6-6Advanced Imaging of adult brain tumors
  • Track 6-7Blood Malignancies
  • Track 6-8Medications for Neuro Oncology
  • Track 6-9Paediatric neuro Oncology Nursing & Care
  • Track 6-10Diagnosis & Treatment of neuro oncology
  • Track 6-11Pediatric Pharmacology and Drug therapy


Neurosurgery or neurological surgery is the medical specialty focused on the prevention, diagnosis, and rehabilitation of disorders which affect any part of the nervous system such as brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system. They help in the diagnosis of intra cerebral hemorrhage.

  • Track 7-1Pediatric Neurosurgery
  • Track 7-2Traumatic injuries
  • Track 7-3Hydrocephalus
  • Track 7-4Cervical and Lum bar spinal stenosis
  • Track 7-5Spinal Disc Herniation
  • Track 7-6skull base surgery
  • Track 7-7Spinal Neuro Surgery
  • Track 7-8Funtional Neurosurgery
  • Track 7-9Cerebrovascular Neurosurgery
  • Track 7-10Cyber knife Radiosurgery
  • Track 7-11Clinical Neurosurgery


Gangliocytomas are rare indolent CNS tumours which are made up of mature neurons arising anywhere within the Neuroaxis. They differ from gangliogliomas as they lack neoplastic glial cells. Treatment involves surgical removal of the tumor. These are Neuroepithelial Tumors which line the ventricles of the brain and produces Cerebrospinal fluid.


  • Track 8-1Hormonal disorders
  • Track 8-2Seizures
  • Track 8-3Headache
  • Track 8-4Ganglioneuroma


Choroid Plexus Tumor arises from Brain tissue that invades nearby tissue and spread widely via the cerebrospinal fluid. Like other brain tumors, choroid plexus tumors are also “graded.” Choroid Plexus Neoplasms are rare, Intraventricular, Primary Central Nervous System (CNS) tumors derived from Choroid Plexus Epithelium that are seen predominantly in children.


  • Track 9-1Choroid Plexus Papilloma (grade 1)
  • Track 9-2Intermediate Grade (grade 2)
  • Track 9-3Atypical Choroid plexus papilloma (grade 3)


A Brainstem glioma is an aggressive and dangerous Cancerous Glioma Tumor in the brainstem which starts in the Brain or Spinal cord tissue and typically spread throughout the Nervous System. It is more diagnosed in children and young adults under the age of twenty. Symptoms of Brainstem glioma can develop slowly and subtly and may go unnoticed for months. A sudden onset of symptoms tends to occur with more rapidly growing, high-grade tumors. In other cases, the symptoms may arise abruptly. Unlike most Brain tumors, Brainstem Glioma is not often treated with Neurosurgery due to complications in vital parts of the Brain. Without treatment, the life expectancy is typically a few months from the time of diagnosis.

  • Track 10-1Focal or low-grade glioma
  • Track 10-2Diffuse intrinsic pontine glioma
  • Track 10-3Radiation therapy with radio sensitizers
  • Track 10-4Loss of balance and Trouble walking
  • Track 10-5Vision and Hearing Problems
  • Track 10-6Headache
  • Track 10-7Unusual Sleepiness
  • Track 10-8Nausea and Vomiting


The Psychosocial and Neurocognitive functioning of several cancer patients and survivors deleteriously affected by various treatments of Malignant tumors such as Chemotherapy, Radiotherapy and Hormonal therapy. Oncology researchers and Clinicians are increasingly Cognizant of the negative effects of Cancer and its treatments on the Brain and its mental processes and Cognitive outcomes. Neuropsychology in Cancer features the current findings on the Neuropsychological effects of the Cancers and their treatments along with the most promising Neuropsychological and behavioural health interventions available to mitigate these deficits.


  • Track 11-1Evolutionary Psychology
  • Track 11-2Sensory Processing
  • Track 11-3Sleep and Communication
  • Track 11-4Learning and Memory
  • Track 11-5Psycho-metrics
  • Track 11-6Neuropsychological Impairment
  • Track 11-7Cognitive testing
  • Track 11-8Incognition
  • Track 11-9Brain-stimulation treatments
  • Track 11-10Bipolar disorder
  • Track 11-11Neuropsychiatric Disorders
  • Track 11-12Addiction
  • Track 11-13Animal Behavior


Angiogenesis theatrically a critical role in the maturation and spread of cancer, it also plays a major role in the transition of tumor cells from a benign state to a malignant (cancerous), leading to the use of angiogenesis evasion in the treatment of cancer.

Angiogenesis is a vital series that facilitates tumor growth and survival. Angiogenesis is a well-controlled path that is systematize by angiogenic, growth, and survival factors that are secreted by the malignant units as well as other corpuscle within the tumour microenvironment.


The Response Assessment in Neuro-Oncology (RANO) Working Group is an international, Multidisciplinary effort to develop new standardized response criteria for Clinical trials in Brain tumors. The Surgery Working Group of RANO identified surgically related End-point evaluation problems that were not addressed in the original Macdonald criteria. Macdonald criteria led to the initiation of an International effort in Neurooncology to develop Novel Response and Progression Assessment Criteria.

  • Track 13-1Cerebrovascular Disease
  • Track 13-2Computational Neuroscience
  • Track 13-3Response Evaluation
  • Track 13-4Trauma and Tumour
  • Track 13-5Macdonald Criteria
  • Track 13-6Clinical Trials


In low-grade Gliomas, stereotactically guided conformal Radiotherapy should lead to a significant reduction in Radiation-associated late toxicity, while in selected groups of high-grade Gliomas the use of adjuvant or Neo-adjuvant Chemotherapy may improve survival. In primitive Neuroectodermal Tumours Prognostic Biological markers have been identified that are undergoing prospective evaluation. In infants the use of post-surgical chemotherapy alone may allow the postponing of Radiotherapy in selected cases. For patients with localized Medulloblastomas a new standard treatment is emerging that uses reduced-dose Craniospinal Radiotherapy followed by Platinum-based chemotherapy, while in Supratentorial primitive Neuroectodermal tumours future treatment will be aimed at improving local control.

  • Track 14-1Central Nervous System Malignancies
  • Track 14-2Primitive Neuroectodermal Tumours
  • Track 14-3platinum-based chemotherapy
  • Track 14-4Whole-brain radiotherapy (WBRT)

The upcoming implementation of a Neurosurgical ablation device that provides controlled therapy for brain lesions those are difficult to reach and treat. Thistool,will allow us to introduce the probe into the tumor and destroy it without having to perform a Surgical Operation or Craniotomy.Recent advances have made treatment for brain tumors much safer and more successful. Some of these newer.

•Antiseizure/Antiepileptic Drugs (AEDs)

•Steroids

•Surgery: The goal of surgery in the treatment of metastasis is to maximally remove tumor while leaving patients with good function

•Radiosurgery: A non-invasive technique that delivers numerous narrow, precisely aimed, highly focused beams of ionizing radiation that converge at a specific point.

 •Radiation therapy: X-rays and other forms of radiation can destroy tumor cells or delay tumor   growth.

•Chemotherapy: The use of drugs to kill rapidly dividing cells. It can be taken orally or intravenously.

•Targeted therapy: The focus on a specific element of a cell, such as molecules or pathways required for cell growth, in order to use them as a target.

  • Track 15-1Computer-Assisted Technology
  • Track 15-2Endoscopy
  • Track 15-3Intraoperative Magnetic Resonance Imaging (MRI)
  • Track 15-4Personalized Vaccines
  • Track 15-5Genomic Sequencing


Occurrence of Cancer related complications are seen during Chemotherapy because the dividing blood cells in bone marrow are also prone to damage from medications used in treatment also many of these side effects can be attributed to low blood counts. In rare cases, some Chemotherapy drugs can cause Heart damage or trigger another cancer such as leukaemia. Some complications seen are

  •    Infection
  •    Fatigue
  •    Bruising
  •    Bleeding
  •    Sleep disturbances


Preventive measures should start before cancer therapy begins, reducing the occurrence of further problems brought about by different treatment modalities.



Nursing is a dealing with assessment, nursing diagnosis and management of brain and nervous system disorders, tumors, brain injuries, trauma, spine injuries, stroke, seizures aneurysms and many more conditions. Critical illness defines severe damage of vital organs like Central nervous system failure, brain damage, and spine injury and there is a chance of life threatening deterioration in the patient’s condition. Critical care is time dependent and delivered by physician to a critically injured patient and requires high complex decision to assess, monitor, manipulate and support vital organ function in order to treat vital organ system failure.


  • Track 17-1Neuro oncology Nursing
  • Track 17-2Addiction Nursing
  • Track 17-3Neurovascular Nursing
  • Track 17-4Brain Nursing


Radiation Oncology encompasses all facet, of research that whack, on the treatment of cancer using radiation. It discloses verdict in molecular and cellular radiation oncology, radiation technology, radiation physics, and clinical oncology.

Radiation Oncology is fabricated up of three unique medical specialties that focus on the treatment of cancer patients with radiotherapy treatment (also known as radiation therapy); videlicet Radiation Oncologists, Radiation Therapists and Radiation Physicists.

  • Track 18-1magnetic resonance imaging (MRI)
  • Track 18-2Stereotactic Radiosurgery(SRS)
  • Track 18-3Magneto Encephalography (MEG)
  • Track 18-4Positron Emission Tomography (PET)
  • Track 18-5Quality Measures of Radiotherapy
  • Track 18-6Intensity modulated radiation therapy(IMRT)
  • Track 18-7Palliative radiotherapy in Neuro Oncology
  • Track 18-8Cellular Radiation Oncology
  • Track 18-9Molecular Radiation Oncology
  • Track 18-10Radioactive compounds in NeuroImaging
  • Track 18-11Clinical Radiation Oncology
  • Track 18-12Brachytherapy
  • Track 18-13Three-dimensional conformal radiation therapy (3D-CRT)
  • Track 18-14Vincristine